Cotinga Pharmaceuticals
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene.COTQF Cotinga Pharmaceuticals Inc. - Seeking Alphaseekingalpha.com/symbol/COTQF...
N/A
Technology
1999
Founded
11-50
Employees
Clinical Development
Industry
Visual (Placeholder)
Profile Information
Name
Cotinga Pharmaceuticals
Industry
Clinical Development
Technology
N/A
Location
Boston, Suffolk County, Massachusetts, United States
Founded
1999
Employees
11-50
Category
Company
Contact Information
Email
ir@cotingapharma.com
Phone
N/A
Address
N/A